Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain

NCT: NCT04662905 · RECRUITING

NCT IDNCT04662905
StatusRECRUITING
Start Date2020-12-15
Completion2027-01-01

Brief Summary

The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.

Frequently Asked Questions

What is Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain?

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain is a clinical trial registered under NCT04662905. Current status: RECRUITING.

What is the status of NCT04662905?

The current status of NCT04662905 (Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain) is: RECRUITING.

When did Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain start?

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain started on 2020-12-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑